|
Treatment patterns and associated adverse events among patients with metastatic triple-negative breast cancer. |
|
|
No Relationships to Disclose |
|
|
Employment - Astellas Pharma |
Stock and Other Ownership Interests - Gilead Sciences; Shire |
|
|
Employment - Truven Health Analytics |
Research Funding - As an employee of Truven, various pharma and biotech companies have funded my work; Astellas Pharma; AstraZeneca; Biomarin; BioVentus; Bristol-Myers Squibb; Genentech; GlaxoSmithKline; Intarcia Therapeutics; Merck; Pfizer; Sirtex Medical; Sunovion; Teva |
Travel, Accommodations, Expenses - Truven Health Analytics |
|
|
Employment - Truven Health Analytics |
|
|
Employment - Truven Health Analytics |
Travel, Accommodations, Expenses - Truven Health Analytics |
|
|
Employment - Astellas Pharma |
Travel, Accommodations, Expenses - Astellas Pharma |
|
|
Employment - Astellas Pharma |
Stock and Other Ownership Interests - Celgene; Jazz Pharmaceuticals |
|
|
Employment - Medivation/Pfizer |
Stock and Other Ownership Interests - Medivation/Pfizer |
Research Funding - Medivation/Pfizer |
Travel, Accommodations, Expenses - Medivation/Pfizer |
|
|
Employment - Medivation/Pfizer |
Stock and Other Ownership Interests - Amgen; Medivation/Pfizer |
|
|
Employment - Astellas Pharma |
Stock and Other Ownership Interests - Abbott Laboratories; Johnson & Johnson |
Travel, Accommodations, Expenses - Astellas Pharma |